Aficamten and Cardiopulmonary Exercise Test Performance

Overview of attention for article published in JAMA Cardiology, November 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 6 news outlets
blogs: 2 blogs
twitter: 16 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

Defibrillator Positioning; PFA for PVC Ablation; Harvey Weinstein's Heart Surgery

MedPage Today, 10 Sep 2024

Cardiology > Prevention Recent developments of interest in cardiovascular medicine by Nicole Lou, September 10, 2024 Not all…

Aficamten improves exercise tolerance in patients with HOCM

The Medical News, 05 Sep 2024

Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their…

Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial

MarketScreener, 05 Sep 2024

Research JAMA Cardiology | Original Investigation Aficamten and Cardiopulmonary Exercise Test Performance A Substudy of the…

Heart drug improves exercise tolerance in clinical trial of patients with hypertrophic obstructive cardiomyopathy

MedicalXpress, 04 Sep 2024

Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.